Companies: 10,795·Total market cap: $144.5T
Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUSAMEXHealthcare● Active
$1.13
$-0.15(-11.71%)
Market Cap$1421211
P/E Ratio
52W High$40.31
52W Low$1.17

Apimeds Pharmaceuticals US, Inc (APUS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · APUS · as of May 4, 2026

Latest filing snapshot

12
+0+0.00%vs prior year

Apimeds Pharmaceuticals US, Inc (APUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
12
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
Net Income / Employee
$-500.1K
Market Cap
$2M

APUS Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-05-0412+0+0.00%
2025-04-1512

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic
#SymbolCompanyEmployees
#1
Myomo, Inc.
MYO
Myomo, Inc.
184
#2
IGC Pharma, Inc.
IGC
IGC Pharma, Inc.
67
#3
NextCure, Inc.
NXTC
NextCure, Inc.
43
#4
AN2 Therapeutics, Inc.
ANTX
AN2 Therapeutics, Inc.
22
#5
Milestone Scientific Inc.
MLSS
Milestone Scientific Inc.
17
#6
Apimeds Pharmaceuticals US, Inc
APUS
Apimeds Pharmaceuticals US, IncYOU
12
#7
MIRA Pharmaceuticals, Inc.
MIRA
MIRA Pharmaceuticals, Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · APUS peer comparison

About APUS employees

APUS Employees · Headcount

Apimeds Pharmaceuticals US, Inc (APUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Apimeds Pharmaceuticals US, Inc had 12 full-time employees globally. Full-time employees only. Global consolidated headcount.

Apimeds Pharmaceuticals US, Inc's workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

APUS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Apimeds Pharmaceuticals US, Inc had 12 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Apimeds Pharmaceuticals US, Inc employee counthow many employees does Apimeds Pharmaceuticals US, Inc haveAPUS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-05-04